Clinical Trial Update: Effect of Rituximab in Treatment of Membranoproliferative Glomerulonephritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating rituximab for membranoproliferative glomerulonephritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranoproliferative Glomerulonephritis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Assiut University | Conditions: Membranoproliferative Glomerulonephritis | Phase 3 | Status: UNKNOWN